CLINICAL_TRIALS
trial_result
· 2017-03-21
Clinical Trial Update: A Study of LY3154207 in Healthy Participants and Participants With Parkinson's Disease [Phase 1]
Summary
A Phase 1 study of LY3154207 in healthy participants and individuals with Parkinson's disease has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Eli Lilly and Company | Conditions: Parkinson's Disease | Phase 1 | Status: COMPLETED